Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 3 | 2025 | 1014 | 0.900 |
Why?
|
| Thrombosis | 4 | 2023 | 498 | 0.880 |
Why?
|
| Methylprednisolone | 1 | 2025 | 95 | 0.860 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2025 | 298 | 0.750 |
Why?
|
| Venous Thromboembolism | 2 | 2023 | 192 | 0.700 |
Why?
|
| Thrombophilia | 1 | 2021 | 41 | 0.680 |
Why?
|
| Blalock-Taussig Procedure | 2 | 2019 | 46 | 0.680 |
Why?
|
| Blood Coagulation | 1 | 2021 | 134 | 0.660 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 204 | 0.630 |
Why?
|
| Balloon Valvuloplasty | 1 | 2020 | 26 | 0.630 |
Why?
|
| Carotid Artery Injuries | 1 | 2018 | 33 | 0.550 |
Why?
|
| Inflammation | 1 | 2025 | 1478 | 0.520 |
Why?
|
| Extracorporeal Membrane Oxygenation | 4 | 2025 | 675 | 0.510 |
Why?
|
| Head and Neck Neoplasms | 2 | 2013 | 637 | 0.510 |
Why?
|
| Aneurysm, False | 1 | 2018 | 85 | 0.500 |
Why?
|
| Tetralogy of Fallot | 1 | 2018 | 169 | 0.480 |
Why?
|
| Aortic Valve Stenosis | 1 | 2020 | 353 | 0.470 |
Why?
|
| Ventricular Function, Left | 1 | 2020 | 549 | 0.470 |
Why?
|
| Hemorrhage | 5 | 2025 | 493 | 0.460 |
Why?
|
| Heart Ventricles | 1 | 2019 | 762 | 0.440 |
Why?
|
| Tranexamic Acid | 2 | 2025 | 31 | 0.420 |
Why?
|
| Antifibrinolytic Agents | 2 | 2025 | 47 | 0.410 |
Why?
|
| Laryngeal Muscles | 1 | 2013 | 5 | 0.400 |
Why?
|
| Spasm | 1 | 2013 | 46 | 0.390 |
Why?
|
| Dysphonia | 1 | 2013 | 16 | 0.390 |
Why?
|
| Heart Transplantation | 1 | 2019 | 833 | 0.380 |
Why?
|
| Cultural Diversity | 1 | 2013 | 79 | 0.380 |
Why?
|
| Heart Defects, Congenital | 2 | 2025 | 1876 | 0.380 |
Why?
|
| Lymphangioma | 1 | 2012 | 23 | 0.370 |
Why?
|
| Sclerotherapy | 1 | 2012 | 36 | 0.360 |
Why?
|
| Lymphatic Abnormalities | 1 | 2012 | 35 | 0.360 |
Why?
|
| Anticoagulants | 5 | 2025 | 605 | 0.350 |
Why?
|
| Doxycycline | 1 | 2012 | 111 | 0.350 |
Why?
|
| Lung Diseases | 2 | 2025 | 396 | 0.320 |
Why?
|
| Retrospective Studies | 12 | 2025 | 17673 | 0.320 |
Why?
|
| Papillomavirus Infections | 1 | 2013 | 385 | 0.290 |
Why?
|
| Infant | 8 | 2025 | 13299 | 0.280 |
Why?
|
| Pregnancy Complications | 1 | 2013 | 540 | 0.280 |
Why?
|
| Survival Rate | 1 | 2013 | 2140 | 0.280 |
Why?
|
| Child | 13 | 2025 | 26218 | 0.260 |
Why?
|
| Factor XIII | 1 | 2025 | 13 | 0.240 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2025 | 1157 | 0.230 |
Why?
|
| Factor XIII Deficiency | 1 | 2025 | 10 | 0.230 |
Why?
|
| Child, Preschool | 7 | 2025 | 15018 | 0.230 |
Why?
|
| Central Venous Catheters | 1 | 2025 | 50 | 0.220 |
Why?
|
| Catheterization, Central Venous | 1 | 2025 | 140 | 0.210 |
Why?
|
| Venous Thrombosis | 1 | 2025 | 173 | 0.200 |
Why?
|
| Male | 11 | 2025 | 64772 | 0.200 |
Why?
|
| Warfarin | 2 | 2023 | 123 | 0.200 |
Why?
|
| Female | 12 | 2025 | 70560 | 0.190 |
Why?
|
| Adolescent | 6 | 2025 | 20820 | 0.190 |
Why?
|
| Postoperative Complications | 3 | 2025 | 3131 | 0.190 |
Why?
|
| Humans | 18 | 2025 | 130870 | 0.190 |
Why?
|
| Postpartum Hemorrhage | 1 | 2023 | 109 | 0.180 |
Why?
|
| C-Reactive Protein | 1 | 2025 | 445 | 0.180 |
Why?
|
| Treatment Outcome | 5 | 2025 | 12914 | 0.180 |
Why?
|
| Thrombelastography | 1 | 2021 | 66 | 0.170 |
Why?
|
| Infant, Newborn | 4 | 2025 | 8509 | 0.160 |
Why?
|
| Aspirin | 1 | 2021 | 215 | 0.160 |
Why?
|
| Postoperative Period | 1 | 2021 | 330 | 0.150 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2025 | 773 | 0.150 |
Why?
|
| Blood Platelets | 1 | 2021 | 316 | 0.140 |
Why?
|
| Heart Diseases | 1 | 2023 | 504 | 0.140 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2018 | 111 | 0.130 |
Why?
|
| Device Removal | 1 | 2019 | 225 | 0.130 |
Why?
|
| Angiography | 1 | 2018 | 184 | 0.130 |
Why?
|
| Echocardiography | 2 | 2020 | 1127 | 0.130 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2020 | 361 | 0.120 |
Why?
|
| Recovery of Function | 1 | 2018 | 446 | 0.120 |
Why?
|
| Graft Rejection | 1 | 2019 | 558 | 0.120 |
Why?
|
| Hemodynamics | 1 | 2019 | 807 | 0.110 |
Why?
|
| Voice Quality | 1 | 2013 | 21 | 0.100 |
Why?
|
| Speech | 1 | 2013 | 63 | 0.100 |
Why?
|
| Heparin | 2 | 2022 | 204 | 0.080 |
Why?
|
| Recombinant Proteins | 2 | 2023 | 1324 | 0.080 |
Why?
|
| Young Adult | 2 | 2019 | 10042 | 0.070 |
Why?
|
| Comorbidity | 1 | 2013 | 1587 | 0.070 |
Why?
|
| Adult | 2 | 2019 | 31245 | 0.060 |
Why?
|
| Administration, Inhalation | 1 | 2025 | 192 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 2112 | 0.050 |
Why?
|
| Factor IX | 1 | 2023 | 17 | 0.050 |
Why?
|
| Factor VIIa | 1 | 2023 | 21 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 5199 | 0.050 |
Why?
|
| Blood Coagulation Factors | 1 | 2023 | 31 | 0.050 |
Why?
|
| Hirudins | 1 | 2022 | 39 | 0.050 |
Why?
|
| Respiratory Insufficiency | 1 | 2025 | 241 | 0.050 |
Why?
|
| Factor Xa Inhibitors | 1 | 2023 | 59 | 0.050 |
Why?
|
| Pyridones | 1 | 2023 | 148 | 0.040 |
Why?
|
| Fibrinogen | 1 | 2022 | 167 | 0.040 |
Why?
|
| Pregnancy | 1 | 2013 | 7402 | 0.040 |
Why?
|
| Pyrazoles | 1 | 2023 | 358 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2022 | 548 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2022 | 688 | 0.040 |
Why?
|
| Ventricular Function, Right | 1 | 2019 | 127 | 0.040 |
Why?
|
| Surveys and Questionnaires | 1 | 2025 | 4017 | 0.030 |
Why?
|
| Age Factors | 1 | 2019 | 2842 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 6217 | 0.020 |
Why?
|